Who is the manufacturer of ULTRASOUND SCANNER PRO FOCUS 2202?

B-K Medical Aps filed the 510(k) submission for ULTRASOUND SCANNER PRO FOCUS 2202 (K132685).

What is the FDA product code for ULTRASOUND SCANNER PRO FOCUS 2202?

IYN. It is classified under 21 CFR 892.1550 as a Class 2 device in the Radiology panel.

What is the regulatory pathway for ULTRASOUND SCANNER PRO FOCUS 2202?

510(k) clearance (submission type: Traditional).

What are the predicate devices for ULTRASOUND SCANNER PRO FOCUS 2202?

ZONARE ZS3 Ultrasound System (K120703); Philips CX50 Diagnostic Ultrasound System (K111513); Toshiba Aplio 500 TUS-A500 v2.1 (K121422); Toshiba Aplio 400 TUS-A400 v2.1 (K121422); Toshiba Aplio 300 TUS-A300 v2.1 (K121422).

Who can help prepare an FDA 510(k) submission like ULTRASOUND SCANNER PRO FOCUS 2202?

Innolitics — a medical-device software consultancy — provides regulatory and engineering support for FDA 510(k) submissions. See https://innolitics.com/services/510ks/ or contact https://innolitics.com/contact.

ULTRASOUND SCANNER PRO FOCUS 2202

K132685 · B-K Medical Aps · IYN · Jan 6, 2014 · Radiology

Device Facts

Record ID	K132685
Device Name	ULTRASOUND SCANNER PRO FOCUS 2202
Applicant	B-K Medical Aps
Product Code	IYN · Radiology
Decision Date	Jan 6, 2014
Decision	SESE
Submission Type	Traditional
Regulation	21 CFR 892.1550
Device Class	Class 2
Attributes	Pediatric

Intended Use

Diagnostic ultrasound imaging or fluid flow analysis of the human body as follows: Fetal, Obstetrics, Abdominal, Intraoperative, Neurosurgery, Small organ, Pediatric, Neonatal Cephalic, Adult Cephalic, Cardiac, Transrectal, Transvaginal, Transurethral, Peripheral Vascular, Musculoskeletal.

Device Story

Ultrasound Scanner Pro Focus 2202 is a diagnostic ultrasound system for B-mode, M-mode, CWD, PWD, CFM, tissue harmonic, and contrast harmonic imaging. System accepts ultrasound signals via linear, convex, phased array, and mechanical sector transducers. Optional features include ECG signal superimposition, 3D volume reconstruction from 2D images, and Vector Flow Imaging (VFI) for axial/transverse velocity visualization. Device performs geometric measurements and calculations for vascular, urology, cardiology, and OB/GYN applications; guides biopsy/puncture needles. Used in clinical settings by healthcare professionals. Output displayed on screen for diagnostic assessment, supporting clinical decision-making in various anatomical applications.

Clinical Evidence

Bench testing only. No clinical data provided. System safety and effectiveness established through compliance with IEC 60601-1 (electrical/mechanical safety) and AIUM 1998 standards for acoustic output measurement. Patient contact materials comply with ISO 10993-1.

Technological Characteristics

System supports B, M, CWD, PWD, CFM, tissue/contrast harmonic imaging. Transducers: linear, convex, phased array, mechanical sector. Patient contact materials: ISO 10993-1 compliant. Acoustic output: Ispta ≤ 720 mW/cm², MI ≤ 1.9, TI ≤ 6.0. Connectivity: supports optional ECG input. Software performs geometric measurements and 3D reconstruction.

Indications for Use

Indicated for fetal, obstetric, abdominal, intraoperative, neurosurgical, small organ, pediatric, neonatal cephalic, adult cephalic, cardiac, transrectal, transvaginal, transurethral, peripheral vascular, and musculoskeletal ultrasound imaging and fluid flow analysis in patients requiring diagnostic ultrasound.

Regulatory Classification

Identification

An ultrasonic pulsed doppler imaging system is a device that combines the features of continuous wave doppler-effect technology with pulsed-echo effect technology and is intended to determine stationary body tissue characteristics, such as depth or location of tissue interfaces or dynamic tissue characteristics such as velocity of blood or tissue motion. This generic type of device may include signal analysis and display equipment, patient and equipment supports, component parts, and accessories.

Predicate Devices

ZONARE ZS3 Ultrasound System (K120703)
Philips CX50 Diagnostic Ultrasound System (K111513)
Toshiba Aplio 500 TUS-A500 v2.1 (K121422)
Toshiba Aplio 400 TUS-A400 v2.1 (K121422)
Toshiba Aplio 300 TUS-A300 v2.1 (K121422)

Related Devices

K132346 — ULTRASOUND SCANNER PRO FOCUS 2202 · B-K Medical Aps · Jan 10, 2014
K100919 — PRO FOCUS 2202, PRO FOCUS 2202 UV MODEL: TYPE 2202 · B-K Medical Aps · Dec 16, 2011
K123254 — ULTRASOUND SCANNER FLEX FOCUS · B-K Medical Aps · Feb 13, 2013
K043524 — ULTRASOUND SCANNER PRO FOCUS, MODEL 2202 · B-K Medical A/S · Jan 13, 2005
K043554 — ULTRASOUND SCANNER MINI FOCUS, MODEL 1402 · B-K Medical A/S · Jan 14, 2005

Submission Summary (Full Text)

{0}------------------------------------------------ - 6 2014 ## 510(k) Summary: This summary is provided as part of this Premarket Notification in compliance with 21CRF, Section 807.92. Submitters name: B-K Medical Address: Mileparken.34, DK2730 Herlev. Denmark Phone: +45 44528100 Fax: +45 44528199 Contact person: Gert Nielsen, Regulatory Manager Date prepared: August 23. 2013 Trade name: Ultrasound Scanner Pro Focus 2202 Common name: Diagnostic Ultrasound System Classification names: Ultrasonic Pulsed Echo Imaging System (90 IYO. CFR 892.1560) Ultrasonic Pulsed Doppler Imaging System (90 IYN, CFR 892.1560) (90 ITX, CFR 892.1570) Diagnostic Ultrasonic Transducer Identification of predicate, legally marketed device: The predicate device(s) is(are): - ZONARE Medical Systems Inc .: . ZONARE ZS3 Ultrasound System (K120703) Transducer Model Number: C 10-3 - . Philips Healthcare, Inc .: CX50 Diagnostic Ultrasound System (K111513) Transducer Type: C8-5 - Toshiba America Medical Systems, Inc .: . Diagnostic Ultrasound System (K121422) - o Aplio 500 TUS-A500 v2.1 - o Aplio 400 TUS-A400 v2.1 - Aplio 300 TUS-A300 v2.1 ୍ Transducer Model Number: PVT-712BT ### Device description: 2202 supports the following scanning modes and combinations thereof: B-mode. M-mode. CWD-mode, PWD mode and CFM mode. Tissue harmonic imaging. Contrast harmonic imaging. An optional ECG signal can be superimposed the ultrasound information in all modes and mode combinations. An optional 3-D unit can reconstruct a series of 2-D images into a single 3-D volume and display this on the screen. The system can perform simple geometric measurements, and perform calculations in the areas of Vascular, Urology, Cardiology and OB/GYN applications, The system can guide biopsy- and puncture needles. An optional Vector Flow Imaging (VFI) module: Color Flow Mapping (CFM) imaging mode with the ability to visualize both the axial and the transverse velocity. ### Transducers Transducers are linear and convex phased arrays and mechanical sector. The patient contact materials comply with ISO10993-1 {1}------------------------------------------------ All transducers used together with 2202 are Track 3 transducers. ### Acoustic output The system will assure that the acoustic output always will stay below the pre-amendments upper limits i.e. Ispta ≤ 720 m W/cm² and MI ≤ 1.9 (Track 3. non ophthalmic). The Thermal Index values are maximum 6.0, i.e. TI ≤ 6.0 ### Clinical measurement accuracy. Clinical measurements and calculations are described and accuracies are provided with the User Guide. ### Thermal, mechanical and electrical safety. The scanner 2202 has been tested by a recognized, certified body according to IEC 60601-1. ### Acoustic Output Reporting The Acoustic Output Reporting is made according to the standards required by "Information for Manufacturers Seeking Clearance of Diagnostic Ultrasound Systems and Transducers, FDA, CDRH, September 30, 2008" The acoustic output is measured and calculated according to: * Acoustic Output Measurement Standard for Diagnostic Ultrasound Equipment" (AIUM 1998). ### Intended use. See comparison below {2}------------------------------------------------ #### Technological characteristics compared to the predicate device(s). The predicate device(s) has the same major technological characteristics as the subject device, see comparison below. Comparison with the predicate devices mentioned above from: | Supplier | BK Medical Systems | ZONARE Medical Systems | Philips | Toshiba | Comparison | |------------------------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------| | 510K No. | K043524,K100919 | K120703 | K123754 | K121422 | Comparable | | Intended use | Diagnostic ultrasound imaging or fluid flow analysis of the human body as follows: | Diagnostic Ultrasound Imaging and fluid flow analysis in the following applications: | Diagnostic Ultrasound Imaging and fluid flow analysis in the following applications: | Visualization of structures and dynamic process with the human body using ultrasound and to provide image information for diagnosis in the following clinical applications: | Comparable | | Indications for use | Abdominal Fetal (incl Obstetrics) Intraoperative Transurethral Neurosurgery Pediatrics Small Parts (organs) Neonatal Cephalic Adult Cephalic Cardiac Transrectal Transvaginal Peripheral vascular Muskulo-skeletal (conventional and superficial) | Opthalmic. Fetal/Obstetric. Gynecological Abdominal (renal, TYN/Pelvic; Intra- operative (abdominal, thoracic, and vascular, Intra-operative neurological, Pediatric, Small organ (thyroid, breast, testes, etc). Adult Cephalic, Neonatal Cephalic, Trans-rectal, Trans-vaginal, Trans-cranial, Trans-esophageal (non-cardiac and cardiac). Musculoskeletal (conventional & Superficial), 3D/4D, Cardiac Adult./Pediatrics/Fetal. Echo, Intra-Cardiac. Pelvic, Perpheral vascular, harmonic tissue and contrast imaging and tissue elasticity, Vet and others | Opthalmic. Intracardiac echo, Intraoperative, Laparoscopic. Fetal, Abdominal, Pediatric. Small organ, Adult Cephalic. Neonatal Cephalic, Transvaginal, Musculoskeletal, Gynecological, Cardiac Adult, Cardiac Pediatric, Trans-Esophogeal (Cardiac), Peripheral Vessel, Other (Carotid) | abdominal, intra- operative (abdominal). Pediatric, Small organs. Neonatal Cephalic Adult Cephalic Trans-vaginal, Trans-rectal Musculoskeletal (conventional and superficial) Cardiac Pediatric Cardiac Adult Peripheral Vascular Transesophageal | Comparable | | Transducer specific | | | | | | | 510K No. | K043524 | K120703 | K123754 | K121422 | Comparable | | Indication for use | Neonatal Cephalic | Neonatal Cephalic | Neonatal Cephalic | Neonatal Cephalic | Comparable | | Frequency range | 10-3.8 MHz | 10-3 MHz | 8-5 MHz | 10-3 MHz | Comparable | ### Summary of Clinical Tests: This submission introduces no new indications for use, modes, features or technologies relative to the predicate devices that require clinical testing. The clinical safety and effectiveness of ultrasound system with these characteristics are well accepted for both predicate and subject devices. . {3}------------------------------------------------ K132685 page 4 of 4 Conclusion: The device ProFocus 2202 and the probe N13C5 type 8862 in this application has similar intended uses, and in particular the subject for the submission, the addition of the new application Neonatal Cephalic, is the same. B-K Medical ApS therefore considers. that 2202 is substantially equivalent to the predicate devices. · . {4}------------------------------------------------ DEPARTMENT OF HEALTH & HUMAN SERVICES Image /page/4/Picture/1 description: The image shows the logo for the U.S. Department of Health & Human Services. The logo consists of a circular seal with the words "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" around the perimeter. Inside the circle is a stylized symbol that resembles an abstract caduceus or a bird-like figure with three wing-like shapes. Public Health Service Food and Drug Administration 10903 New Hampshire Avenue Document Control Center - WO66-G609 Silver Spring, MD 20993-0002 January 6, 2014 B-K Medical ApS % Mr. Gert Nielsen Regulatory Affairs Manager Mileparken 34 Herlev DK-2730 DENMARK Re: K132685 Trade/Device Name: Ultrasound Scanner Pro Focus 2202 Regulation Number: 21 CFR 892.1560 Regulation Name: Ultrasonic pulsed echo imaging system Regulatory Class: II Product Code: IYO, IYN, ITX Dated: December 5, 2013 Received: December 19, 2013 Dear Mr. Nielsen: We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading. This determination of substantial equivalence applies to the following transducers intended for use with the Ultrasound Scanner Pro Focus 2202, as described in your premarket notification: Transducer Model Number N13C5 Type 8862 If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register. Please be advised that FDA 's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act {5}------------------------------------------------ Page 2 - Mr. Gert Nielsen or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting (reporting of medical device-related adverse events) (21 CFR 803); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050. If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Division of Small Manufacturers, International and Consumer Assistance at its tollfree number (800) 638 2041 or (301) 796-7100 or at its Internet address http://www.fda.gov/MedicalDevices/ResourcesforYou/Industry/default.htm. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to http://www.fda.gov/McdicalDevices/Safetv/ReportaProblem/dcfault.htm for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance. You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address http://www.fda.gov/MedicalDevices/ResourcesforYou/Industry/default.htm. Sincerely yours, Sm.7) for Janine M. Morris Director, Division of Radiological Health Office of In Vitro Diagnostics and Radiological Health Center for Devices and Radiological Health Enclosure {6}------------------------------------------------ # Indications for Use ### 510(k) Number (if known): K132685 Device Name: Ultrasound Scanner Pro Focus 2202 Ultrasound Transducer N13C5, Type 8862 Indications For Use: Ultrasound scanner and transducers for B, Tissue and Contrast Harmonic Imaging, M, PWD, CWD, Color Doppler, Vector Flow Imaging and combined mode imaging. Signal analysis and display. Guidance of biopsy needles, geometrical measurements and calculation of parameters. Non monitoring ECG for superimposing the ultrasound information. An optional 3-D unit can reconstruct a series of 2-D images into a single 3-D volume and display this on the screen. An optional Vector Flow Imaging (VFI) module: Color Flow Mapping (CFM) imaging mode with the ability to visualize both the axial and the transverse velocity. Clinical applications: Ultrasound Scanner Pro Focus 2202: Fetal, Obstetrics, Abdominal, Intraoperative, Neurosurgery, Small organ, Pediatric, Neonatal Cephalic, Adult Cephalic, Cardiac, Transrectal, Transvaginal, Transurethral. Peripheral Vascular, Musculoskeletal. Ultrasound Transducer N13C5, Type 8862: Neonatal Cephalic. Details on specific Indication for Use forms Prescription Use (Part 21 CFR 801 Subpart D) AND/OR Over-The-Counter Use (21 CFR 807 Subpart C) (PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED) Concurrence of CDRH; Office of In Vitro Diagnostics and Radiological Health (OlR) Smh.7) Page 1 of ___1_ (Division Sign-Off) Division of Radiological Health/OIR 510(k) {7}------------------------------------------------ ### Diagnostic Ultrasound Indications for Use Form #### System: 2202 ### Fill out one form for each ultrasound system and each transducer. ' Intended Use: Diagnostic ultrasound imaging or fluid flow analysis of the human body as follows: | Clinical Application | Mode of Operation | | | | | | | | | Other | |------------------------------------------------|-------------------|---|---|-----|-------------------------|---------------|-------------------|------------------------|----------------------|-------| | | A | B | M | PWD | Tissue-harmonic imaging | Color Doppler | Amplitude Doppler | Color Velocity Imaging | Combined (specify 1) | | | Ophthalmic | | | | | | | | | | | | Fetal 2) (K0435524) | P | P | P | P | P | P | P | | P | | | Abdominal (K0435524) | P | P | P | P | P | P | P | | P | | | Intraoperative (specify) (K0435524) | P | P | P | P | P | P | P | | P | | | Intraoperative Neurological (K0435524) | P | P | P | P | P | P | P | | P | | | Pediatric (K0435524) | P | P | P | P | P | P | P | | P | | | Small Organ (specify) (K0435524) | P | P | P | P | P | P | P | | P | | | Neonatal Cephalic | N | N | N | N | N | N | N | | N | | | Adult Cephalic (k070077) | P | P | P | P | P | P | P | | P | | | Cardiac (K0435524) | P | P | P | P | P | P | P | | P | | | Transesophageal | | | | | | | | | | | | Transrectal (K0435524) | P | P | P | P | P | P | P | | P | | | Transvaginal (K0435524) | P | P | P | P | P | P | P | | P | | | Transurethral (K0435524) | P | P | P | P | P | P | P | | P | | | Intravascular | | | | | | | | | | | | Peripheral Vascular (K0435524). (K100919 3) | P | P | P | P | P | P | P | | P | | | Laparoscopic | | | | | | | | | | | | Musculo-skeletal Conventional (K0435524) | P | P | P | P | P | P | P | | P | | | Musculo-skeletal Superficial (K0435524) | P | P | P | P | P | P | P | | P | | | Other (specify) | | | | | | | | | | | N= new indication; P= previously cleared by FDA; E= added under Appendix E B+M, B+D, B+C. B+D+C. Additional Comments:_ 1) B mode includes Tissue Harmonic Imaging D is PWD, C is Color Doppler, Fetal is often called Obstetrics 2) Vector Flow Imaging ਤੇ (PLEASE DO NOT WRITE BELOW THIS LINE · CONTINUE ON ANOTHER PAGE IF NEEDED) ' Concurrence of CDRH; Office of In Vitro Diagnostics and Radiological Health (OIR) Prescription Use (Per 21 CFR 801.109) {8}------------------------------------------------ ### DIAGNOSTIC ULTRASOUND INDICATIONS FOR USE FORM ... ... | System: | | |-------------|--| | Transducer: | | 2202 8862 Intended Use: Diagnostic ultrasound imaging or fluid flow analysis of the human body as follows: | Clinical Application | | Mode of Operation | | | | | | | |----------------------|------------------------------------------|-------------------|---|-----|-----|---------|-------------|-----------| | General | Specific | B | M | PWD | CWD | Color | Combined | Amplitude | | (Track I Only) | (Tracks I & III) | | | | | Doppler | (Specify 1) | Doppler | | Ophthalmic | Ophthalmic | | | | | | | | | | Fetal | | | | | | | | | | Abdominal | | | | | | | | | | Intra-operative (Specify 2) (K043524) | E | E | E | | E | E | E | | | Intra-operative (Neuro) (K043524) | E | E | E | | E | E | E | | | Laparoscopic | | | | | | | | | Fetal Imaging | Pediatric (K043524) | E | E | E | | E | E | E | | | (K043524) | | | | | | | | | & Other | Small Organ (Specify) | | | | | | | | | | Neonatal Cephalic | N | N | N | | N | N | N | | | Adult Cephalic | | | | | | | | | | Trans-rectal | | | | | | | | | | Trans-vaginal | | | | | | | | | | Trans-urethral | | | | | | | | | | Trans-esoph. (non-Card.) | | | | | | | | | | Musculo-skel. | | | | | | | | | | (Conventional) | | | | | | | | | | Musculo-skel. (Superficial) | | | | | | | | | | Intra-luminal | | | | | | | | | | Other (Specify) | | | | | | | | | Cardiac | Cardiac Adult | | | | | | | | | | Cardiac Pediatric | | | | | | | | | | Trans-esoph. (Cardiac) | | | | | | | | | | Other (Specify) | | | | | | | | | Peripheral | Peripheral vessel | | | | | | | | | Vessel | Other (Specify) | | | | | | | | N= new indication; P= previously cleared by FDA; E= added under Appendix E *Examples may include: A-mode, Amplitude Doppler, 3-D Imaging, Harmonic Imaging, Tissue Motion Doppler, Color Velocity Imaging _1) Mode combinations: B+M, B+D, B+C, B+D+C. (D is PWD, C is Color Flow Additional Comments:_ mapping Doppler including Amplitude(power)Doppler)_ 2)Intraoperative: Gall bladder_ (PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED) Concurrence of CDRH; Office of In Vitro Diagnostics and Radiological Health (OIR) Prescription Use (Per 21 CFR 801.109)